CA
CNCR

CoreCap Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

CoreCap Advisors’s Portfolio CNCR Stock Details CNCR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
2024
Q2 		$1.45K Hold
2024
Q1 		$1.79K Buy
2022
Q4 		$42.7K Buy
2022
Q3 		– Sell
2022
Q2 		$138K Buy
2022
Q1 		– Sell
2021
Q4 		$121K Buy